Services on Demand
Print version ISSN 0102-8650
On-line version ISSN 1678-2674
Acta Cir. Bras. vol.18 no.spe São Paulo 2003
Experimental model of induction of diabetes mellitus in rats1
Modelo experimental de indução do diabetes mellitus em ratos
Eliziane Nitz de CarvalhoI; Nestor Antônio Schmidt de CarvalhoII; Lydia Masako FerreiraIII
IPhD student of Plastic Surgery Division of Federal University of São Paulo - Paulista School of Medicine (UNIFESP -EPM).
IIProfessor of Physiology for the Odontology, Nursing and Speech Pathology courses at UNIVALI. Brazil
IIIHead of Plastic Surgery Division of Surgery Department and Coordinator of Post-graduation Program in Reconstructive Plastic Surgery - UNIFESP - EPM. Brazil
ABSTRACT: Diabetes mellitus is a potentially morbid condition with high prevalence worldwide, thus being a major medical concern. Experimental models play an important role in understanding such a disease, which is treatable only. This study describes a rat diabetes mellitus model induced by administering a reduced dose of alloxan, thus greatly reducing the animals death rate.
KEY WORDS: Alloxan. Diabetes. Rats.
RESUMO: O diabetes mellitus é uma condição mórbida da maior importância no contexto da medicina. Este artigo decreve um dos modelos de indução do diabetes mellitus com aloxano, uma das substâncias que provocam a hiperglicemia permanente em várias espécies. Com base na literatura, tem o intuito de estabelecer esse modelo como uma opção para investigar as complicações do diabetes mellitus e seus tratamentos. Tese, ainda, considerações sobre perspectivas de aplicações deste modelo, ainda pouco utilizado.
DESCRITORES: Aloxano. Diabetes. Ratos.
Due to its high prevalence and potential deleterious effects on a patients physical and psychological state, diabetes mellitus, which can result in a morbid condition, is a major medical concern. 1, 2
According to the World Health Organization (WHO) the number of diabetics has doubled in the past few years and is expected to double once again by the year 2025. Today, there are 160,000 diabetics worldwide, 10,000 in
In humans, diabetes mellitus is one of the most prevalent conditions with spontaneous manifestation. In animals, it can be induced by partial pancreatectomy or by the administration of diabetogenic drugs such as alloxan, streptozotocin, ditizona and anti-insulin serum.4
These agents selectively destroy the Langerhans islet β-cells. The best known drug-induced diabetes model is the alloxan diabetes. Alloxan, a derivative of uric acid, as well as of other substances of different chemical groups, cases β-cells to degranulate and consequently degenerate.1, 5, 6, 7, 8, 9, 10, 11,12,13
Alloxan induces irreversible diabetes mellitus after 24 hours following its administration and the condition proves to be chronic by laboratory tests after seven days.
This study describes the method of inducing diabetes mellitus in rats by alloxan administration.
The experimental animal in this model is the male, adult Wistar EPM (Rattus norvegicus alvinus, Rodentia, Mamalia) weighing 250 to 350 g.
After a 48-hour fast, the rats were weighed and anesthetized by her inhalation in a glass dome. A solution of alloxan at 2% diluted in saline at 0.9% was administered to the animals in a single dose corresponding to 40 mg of alloxan per kg of animal weight injected into their penial vein.
Food and water were presented to the animals only 30 minutes after the drug administration.
From the animals subjected to this procedure, 40% developed chronic diabetes mellitus; 20% either developed the condition to a mild or slight degree or did not developed it at all; and the remaining 40% died within the first seek of follow up, probably due to acidosis.
The animals showed the following signs of the condition: polydipsia (abnormal thirst), polyuria (increased urine volume), weight loss (due to lean mass loss), asthenia (weakness due to the inability to use glucose as a source of energy), dehydration (due to the animal bodys attempt to get rid of the excess blood glucose as the normal process of storing glucose in the body cells is impaired).
In order to assess the effect of alloxan and to chemically establish the diabetic condition, an incision was done in any of the four veins in the tail of the rat using a 15 scalpel blade 10 days after induction. A sample of the rats venous blood was collected on a reagent strip 10 days after the diabetes induction procedure for blood glucose level determination using a portable glucose analyzer.
The level of serum glucose considered to be normal in rattus novergicus ranges from 50 to 135 mg/100ml.14 In this study, rats with glucose levels above 200mg/dl were considered as having severe diabetes.
Procedure for alloxan induction of diabetes mellitus
Lying on its back, the animal is given an injection of alloxan in its penial vein (Figure 1).
Incision in a tail vein for determination of glycemia level 10 days after alloxan injection (Figure 2).
The procedure for chemical induction of diabetes mellitus proved to be effective. This experimental model adds to various others and can be used as alternative model in studies carried out in several fields such as plastic surgery.
1. Macedo CS, Capelletti SM, Mercadante MCS, Padovani CR, Spadella CT. Role of metabolic control on diabetic nephorathy. Acta Cir Bras 2002;17 (6): 370-5. [ Links ]
2. Halpern A, Mancini MC, Mancini MMAM. Diabetes mellitus. Rev Bras Med 2000:57. [ Links ]
3. Beretta ALRZ. Campanha de prevenção e diagnóstico do diabetes realizada pela UNIARARAS e prefeitura municipal na cidade de Araras. Laes & Haes 2001; 22(131): 188-200. [ Links ]
4. Cisternas JR. Fisiologia das ilhotas de Langerhans. In: Douglas CR. Tratado de fisiologia aplicada a ciências da saúde. 4th ed.
5. Ahrén R, Sundkvist G. Long Term Effects of Aloxan in Mice. Int J Pancreatol. 1995;2:197-201. [ Links ]
6. Bhattacharya SK. Activity of shilajit on aloxan induced hypoglicaemia in rats. Fitoterapia 1995;116(4):328-32. [ Links ]
7. Calza KC, Marqueti RC, Silveira MPM. Efeito cicatrizante do laser HeNe atuando na cicatrização de tecidos cutâneos em ratos (aloxânicos) diabéticos e normais. Rev Bras Fisioter; 2001; Suppl:28. [ Links ]
9. Dunn JS, Mcletchie NGB.Experimental alloxan diabetes in the rat. Lancet 1943; 245: 484-7. [ Links ]
10. Godoy P, Barreto Neto M.. Pâncreas endócrino. In: Bogliolo L. Patologia 3rd ed. Rio de Janeiro: Guanabara Koogan; 1981. p.1056-60. [ Links ]
11. Machado JLM, Macedo AR, Silva MD, Spadella CT, Montenegro MRG. Caracterização de um modelo experimental de neuropatia em ratos diabéticos induzidos pela aloxana. Acta Cir Bras 2000; 15 (2): 86-93. [ Links ]
12. Oi K, Komori H, Kajimura H. Changes in plasma glucose, insulin, glucagon, cathecolmine, and glicogen contentes in tissue during development of alloxan diabetes in rats. Biochem Mol Med 1997; 62: 70-5. [ Links ]
13. Spadella CT, Bacchi CE, Mercadante MCS, Machado JLM, Schellini AS. Tratamento convencional com insulina versus lesões renais no rato diabético aloxânico. Acta Cir Bras 1995; supl. 2: 103. [ Links ]
14. Harkness JE, Wagner JE. Biologia e clínica de coelhos e roedores. 3rd ed. São Paulo: Roca; 1993. p.48-55. [ Links ]
Conflict of interest: none
Eliziane Nitz de Carvalho
UNIFESP-EPM, Plastic Surgery Division, Surgery Division
Rua Napoleão de Barros, 715, 4º andar
04024-900 São Paulo SP
Tel: (11)557604118 FAX: (11) 55716579
Data do recebimento: 22/ 04/2003
Data da revisão: 18/05/2003
Data da aprovação: 28/07/2003
1 Plastic Surgery laboratory of Plastic Surgery Division of Federal University of São Paulo - Paulista School of Medicine (UNIFESP -EPM).